-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
Submit your manuscript
Scope
The acquisition of somatic genetic aberrations is central to the development of cancer, and the constitutional genetic background of each patient is an essential aspect of their cancer risk and response to therapy. Current technologies provide ever more powerful approaches to study these highly complex phenomena. The specialty section will facilitate the rapid publication of research reports, reviews and commentaries pertaining to the somatic and germline genetics and genomics of cancer. The scope of submissions will range from whole genome to focused studies of individual genes and molecular pathways in oncology. Both basic and translational studies reporting large-scale genomic and transcriptomic data (e.g. gene expression, copy number, DNA polymorphism, epigenetics, and sequence) are appropriate as are studies employing classical and molecular cytogenetic techniques. While focused primarily on the etiology and progression of human cancer, relevant studies in model systems will be considered. In addition, advances in bioinformatics, statistical, and systems approaches to the biological and clinical interpretation of large-scale data sets are also of interest. Genetics/genomics based biomarker development, new rationales for bringing cancer genetics to the oncology clinic and the clinical laboratory as well as technical advances that facilitate progress in cancer genetics are also welcome.Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, AGRICOLA, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts, CLOCKSS, EBSCO, OpenAIRE, Zetoc
PMCID: all published articles receive a PMCID
Cancer Genetics welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Cancer Genetics, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cancer Genetics will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genetics and Oncology.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact genetics.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact genetics@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org